#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Herpes simplex Craniocerebral injury Craniopharyngioma Hyperinsulinaemic hypoglycaemia Ewing's sarcoma Chronic graft versus host disease Ewing's sarcoma recurrent Transferrin decreased C3 glomerulopathy Lymphoma Fontan procedure Dilated cardiomyopathy Urea cycle disorder Dupuytren's contracture Polymyositis More trials…

    Learn about Rare Diseases

    Retinitis pigmentosa – Life with Disease Pleural mesothelioma malignant Haemophilia A without inhibitors – Life with Disease Alternating hemiplegia of childhood – Diagnostics Focal segmental glomerulosclerosis – Treatment Leukoencephalopathy Lysosomal storage disorder – Diagnostics Chronic granulomatous disease – Life with Disease Congenital generalised lipodystrophy – Trials in Disease Langerhans’ cell histiocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    LTI-03 Zofenopril Calcium Trametinib Dimethyl Sulfoxide FOSMANOGEPIX Acp-017 Cd19-Car_Lenti_Allo Ngm707 ZINC CHLORIDE Azelastine Hydrochloride Mesenchymal Cells Frexalimab ZIMISLECEL Basimglurant Lonvoguran Relatlimab Alglucosidase Alfa SAROGLITAZAR HEMIMAGNESIUM Ivonescimab Arbaclofen Urapidil More therapies…

    Learn about Your Condition

    Vulvovaginal candidiasis Malignant melanoma stage II Herpes simplex Muscle hypertrophy Erythema multiforme Morning sickness Mesothelioma Seasonal allergy Bladder cancer recurrent Plasma cell myeloma recurrent Hyperparathyroidism primary Metabolic surgery Systemic lupus erythematosus Tumour of ampulla of Vater Atrial septal defect More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on the Effects of Ozanimod in Patients with Relapsing-Remitting Multiple Sclerosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Multiple sclerosis relapse
    • Multiple sclerosis
    Investigated Drugs:
    • Ozanimod Hydrochloride
    Italy

  • Study on ATX-01 for Adults Aged 18-64 with Myotonic Dystrophy Type 1 (DM1)

    Recruiting

    1 1
    Investigated Drugs:
    • 16-Base Single Stranded Rna Targeting Mir-23B Linked To Oleic Acid
    France Italy The Netherlands Spain

  • Study on the Effectiveness of Denosumab for Treating Acute Charcot Foot in Diabetes Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Neuropathic arthropathy
    Investigated Drugs:
    • Denosumab
    Denmark

  • Study on the Effects of Dronabinol and Palmidrol for Adults with Tourette Syndrome

    Recruiting

    2 1
    Investigated Diseases:
    • Tourette’s disorder
    Investigated Drugs:
    • Dronabinol
    • Palmidrol
    Germany

  • Study on Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years

    Recruiting

    3 1 1
    Investigated Diseases:
    • Migraine with aura
    • Migraine without aura
    • Migraine
    Investigated Drugs:
    • Rimegepant
    Poland Spain Sweden

  • Study of doxecitine and doxribtimine oral solution for adult patients with Thymidine Kinase 2 (TK2) Deficiency

    Recruiting

    2 1 1
    Investigated Diseases:
    • Mitochondrial myopathy
    Investigated Drugs:
    • Doxecitine
    • Doxribtimine
    Spain
Previous Page
1 … 44 45 46 47 48 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!